Eligibility Diabetes Mellitus, Type 2 NCT00843232

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
stable weight (<5% variation) within the last three months
Beskrivning

Stable body weight | Variability Percentage Duration

Datatyp

boolean

Alias
UMLS CUI [1]
C0517386
UMLS CUI [2,1]
C2827666
UMLS CUI [2,2]
C0439165
UMLS CUI [2,3]
C0449238
age: 35 to 50 years old for middle-age group, and 65 to 80 y old for elderly group
Beskrivning

Age | Middle Age Group | Elderly Group

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0026062
UMLS CUI [2,2]
C0441833
UMLS CUI [3,1]
C0001792
UMLS CUI [3,2]
C0441833
body mass index (bmi): 20 to 29.9kg/m2
Beskrivning

Body mass index

Datatyp

boolean

Alias
UMLS CUI [1]
C1305855
t2dm with diagnosis above 35 years and less than 5 years (middle-age group)
Beskrivning

Diabetes Mellitus, Non-Insulin-Dependent | Middle Age Group

Datatyp

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0026062
UMLS CUI [2,2]
C0441833
t2dm with diagnosis above 65 years and less than 5 years (elderly group)
Beskrivning

Diabetes Mellitus, Non-Insulin-Dependent | Elderly Group

Datatyp

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0001792
UMLS CUI [2,2]
C0441833
use of oral antidiabetic drugs (that must at stable dose within the last 3 months)
Beskrivning

Antidiabetics Oral Dose Stable

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C0178602
UMLS CUI [1,4]
C0205360
not have participated in any study of intervention with drugs in the last six months.
Beskrivning

Absence Study Subject Participation Status Investigational New Drugs

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C0013230
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of estrogen, progestogen, active antipsychotics and systemic corticosteroids
Beskrivning

Estrogens | Progestins | Antipsychotic Agents | CORTICOSTEROIDS FOR SYSTEMIC USE

Datatyp

boolean

Alias
UMLS CUI [1]
C0014939
UMLS CUI [2]
C0033306
UMLS CUI [3]
C0040615
UMLS CUI [4]
C3653708
use of dpp-iv inhibitors and incretin mimetics (current or within 1 month before)
Beskrivning

Dipeptidyl Peptidase-4 Inhibitor | Incretin mimetic product

Datatyp

boolean

Alias
UMLS CUI [1]
C3537225
UMLS CUI [2]
C1562104
continuous use of insulin or glitazone
Beskrivning

Insulin | Thiazolidinediones

Datatyp

boolean

Alias
UMLS CUI [1]
C0021641
UMLS CUI [2]
C1257987
hepatic cirrhosis, renal failure or any clinical condition with impaired insulin sensitivity
Beskrivning

Liver Cirrhosis | Kidney Failure | Medical condition Insulin Sensitivity Impaired

Datatyp

boolean

Alias
UMLS CUI [1]
C0023890
UMLS CUI [2]
C0035078
UMLS CUI [3,1]
C3843040
UMLS CUI [3,2]
C0920563
UMLS CUI [3,3]
C0221099
smoking
Beskrivning

Tobacco use

Datatyp

boolean

Alias
UMLS CUI [1]
C0543414
obesity
Beskrivning

Obesity

Datatyp

boolean

Alias
UMLS CUI [1]
C0028754
uncontrolled systemic or disabling diseases
Beskrivning

Systemic disease Uncontrolled | Disabling disease Uncontrolled

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0442893
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0596452
UMLS CUI [2,2]
C0205318
t2dm treated by non pharmacological methods
Beskrivning

Non-Insulin-Dependent Diabetes Mellitus Treated | Pharmacotherapy Absent

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C1522326
UMLS CUI [2,1]
C0013216
UMLS CUI [2,2]
C0332197
patients submitted to bariatric surgery
Beskrivning

Patients Submitted Bariatric Surgery

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1515023
UMLS CUI [1,3]
C1456587
latent autoimmune diabetes of the adult (positive anti-gad antibodies)
Beskrivning

Latent Autoimmune Diabetes in Adults | Anti-GAD antibody positive

Datatyp

boolean

Alias
UMLS CUI [1]
C1739108
UMLS CUI [2]
C1167896

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT00843232

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Stable body weight | Variability Percentage Duration
Item
stable weight (<5% variation) within the last three months
boolean
C0517386 (UMLS CUI [1])
C2827666 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
Age | Middle Age Group | Elderly Group
Item
age: 35 to 50 years old for middle-age group, and 65 to 80 y old for elderly group
boolean
C0001779 (UMLS CUI [1])
C0026062 (UMLS CUI [2,1])
C0441833 (UMLS CUI [2,2])
C0001792 (UMLS CUI [3,1])
C0441833 (UMLS CUI [3,2])
Body mass index
Item
body mass index (bmi): 20 to 29.9kg/m2
boolean
C1305855 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | Middle Age Group
Item
t2dm with diagnosis above 35 years and less than 5 years (middle-age group)
boolean
C0011860 (UMLS CUI [1])
C0026062 (UMLS CUI [2,1])
C0441833 (UMLS CUI [2,2])
Diabetes Mellitus, Non-Insulin-Dependent | Elderly Group
Item
t2dm with diagnosis above 65 years and less than 5 years (elderly group)
boolean
C0011860 (UMLS CUI [1])
C0001792 (UMLS CUI [2,1])
C0441833 (UMLS CUI [2,2])
Antidiabetics Oral Dose Stable
Item
use of oral antidiabetic drugs (that must at stable dose within the last 3 months)
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0205360 (UMLS CUI [1,4])
Absence Study Subject Participation Status Investigational New Drugs
Item
not have participated in any study of intervention with drugs in the last six months.
boolean
C0332197 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Estrogens | Progestins | Antipsychotic Agents | CORTICOSTEROIDS FOR SYSTEMIC USE
Item
use of estrogen, progestogen, active antipsychotics and systemic corticosteroids
boolean
C0014939 (UMLS CUI [1])
C0033306 (UMLS CUI [2])
C0040615 (UMLS CUI [3])
C3653708 (UMLS CUI [4])
Dipeptidyl Peptidase-4 Inhibitor | Incretin mimetic product
Item
use of dpp-iv inhibitors and incretin mimetics (current or within 1 month before)
boolean
C3537225 (UMLS CUI [1])
C1562104 (UMLS CUI [2])
Insulin | Thiazolidinediones
Item
continuous use of insulin or glitazone
boolean
C0021641 (UMLS CUI [1])
C1257987 (UMLS CUI [2])
Liver Cirrhosis | Kidney Failure | Medical condition Insulin Sensitivity Impaired
Item
hepatic cirrhosis, renal failure or any clinical condition with impaired insulin sensitivity
boolean
C0023890 (UMLS CUI [1])
C0035078 (UMLS CUI [2])
C3843040 (UMLS CUI [3,1])
C0920563 (UMLS CUI [3,2])
C0221099 (UMLS CUI [3,3])
Tobacco use
Item
smoking
boolean
C0543414 (UMLS CUI [1])
Obesity
Item
obesity
boolean
C0028754 (UMLS CUI [1])
Systemic disease Uncontrolled | Disabling disease Uncontrolled
Item
uncontrolled systemic or disabling diseases
boolean
C0442893 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0596452 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Non-Insulin-Dependent Diabetes Mellitus Treated | Pharmacotherapy Absent
Item
t2dm treated by non pharmacological methods
boolean
C0011860 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
C0013216 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Patients Submitted Bariatric Surgery
Item
patients submitted to bariatric surgery
boolean
C0030705 (UMLS CUI [1,1])
C1515023 (UMLS CUI [1,2])
C1456587 (UMLS CUI [1,3])
Latent Autoimmune Diabetes in Adults | Anti-GAD antibody positive
Item
latent autoimmune diabetes of the adult (positive anti-gad antibodies)
boolean
C1739108 (UMLS CUI [1])
C1167896 (UMLS CUI [2])